30 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 30 of 30 clinical reviews.
Can you take low-dose naltrexone (LDN) with acetaminophen? A clinician-grade review of the pharmacokinetic overlap, hepatic risk, monitoring protocols, and dose-adjustment strategies.
A clinical deep-dive into the pharmacokinetic and pharmacodynamic interaction between low-dose naltrexone (LDN) and apixaban, covering CYP3A4/P-gp mechanisms, bleeding risk, monitoring parameters, and patient counseling points.
Clinical review of the drug interaction between low-dose naltrexone (LDN) and atorvastatin. Covers CYP3A4 metabolism overlap, hepatic monitoring, severity rating, and dose-adjustment guidance.
Clinical analysis of the low-dose naltrexone (LDN) and benzodiazepines interaction, covering mechanism, severity, monitoring requirements, and dose adjustment guidance.
Can you take low-dose naltrexone (LDN) with bupropion? A clinician-level review of CYP2D6 inhibition, seizure risk, pharmacodynamic effects, monitoring protocols, and dose-adjustment strategies.
Clinical review of the pharmacokinetic and pharmacodynamic interaction between low-dose naltrexone (LDN) and clopidogrel, including CYP metabolism overlap, severity rating, monitoring protocols, and patient counseling.
A clinician-reviewed guide to the low-dose naltrexone and diphenhydramine drug interaction, covering pharmacokinetic and pharmacodynamic mechanisms, severity, monitoring parameters, and practical counseling points.
Clinical review of the low-dose naltrexone (LDN) and estradiol HRT interaction, including pharmacokinetic mechanisms, safety data, monitoring recommendations, and dose-adjustment guidance.
Can you take low-dose naltrexone (LDN) with finasteride? A physician-reviewed guide covering CYP metabolism, pharmacodynamic profiles, monitoring protocols, and dose-adjustment considerations.
A physician-reviewed guide to the low-dose naltrexone and gabapentin drug interaction, covering pharmacokinetics, CNS sedation risk, renal considerations, and monitoring protocols.
Clinical review of the drug interaction between low-dose naltrexone (LDN) and hormonal contraceptives. Covers CYP metabolism, pharmacodynamic overlap, severity rating, monitoring, and patient counseling.
A clinician-level review of the low-dose naltrexone and levothyroxine interaction, covering mechanism, severity, timing, monitoring, and dose-adjustment guidance with primary literature citations.
Can you take low-dose naltrexone (LDN) with metformin? A detailed clinical review of pharmacokinetic and pharmacodynamic interactions, monitoring recommendations, and dose-adjustment guidance.
Can you take low-dose naltrexone with ibuprofen or naproxen? A physician-reviewed guide covering the pharmacology, real risks, monitoring requirements, and patient counseling for this drug combination.
A physician-reviewed breakdown of the pharmacodynamic and pharmacokinetic interaction between low-dose naltrexone (LDN) and opioids including oxycodone, hydrocodone, and tramadol. Includes mechanisms, severity ratings, monitoring parameters, and patient counseling points.
Can you take low-dose naltrexone with omeprazole or pantoprazole? A clinician-reviewed guide covering CYP metabolism, absorption timing, severity rating, dose adjustments, and monitoring.
A physician-reviewed guide to the pharmacodynamic and clinical interaction between low-dose naltrexone (LDN) and prednisone, including mechanism, severity, monitoring parameters, and patient counseling.
Can you take low-dose naltrexone (LDN) with pregabalin? A physician-reviewed guide covering pharmacokinetic independence, pharmacodynamic overlap, monitoring parameters, and dose-adjustment considerations.
Can you take low-dose naltrexone (LDN) with progesterone hormone replacement therapy? Review of pharmacokinetic overlap, sedation risk, CYP3A4 metabolism, monitoring recommendations, and clinical guidance.
A clinical deep-dive into the pharmacokinetic and pharmacodynamic interaction between low-dose naltrexone (LDN) and rivaroxaban, including CYP3A4/P-gp mechanisms, bleeding risk, monitoring parameters, and patient counseling guidance.
Can you take low-dose naltrexone (LDN) with rosuvastatin? A physician-reviewed guide covering pharmacokinetic mechanisms, clinical risk, monitoring labs, and dose-adjustment protocols.
Can you take low-dose naltrexone (LDN) with sildenafil? A physician-reviewed guide covering pharmacokinetic overlap, blood pressure risks, CYP3A4 metabolism, monitoring protocols, and dose-adjustment strategies.
A physician-reviewed guide to the pharmacokinetic and clinical interaction between low-dose naltrexone (LDN) and simvastatin, covering CYP3A4 pathways, rhabdomyolysis risk, monitoring parameters, and dose-adjustment guidance.
Clinical guide to combining low-dose naltrexone (LDN) with SNRIs like venlafaxine and duloxetine, covering mechanism, risk severity, monitoring protocols, and dose adjustments.
Clinical analysis of the interaction between low-dose naltrexone (LDN) and SSRIs like sertraline and escitalopram, covering mechanism, severity, monitoring, and dose adjustment.
Can you take low-dose naltrexone (LDN) with tadalafil? A physician-reviewed guide covering CYP metabolism, pharmacodynamic profiles, monitoring parameters, and dose-adjustment recommendations.
Clinical review of the low-dose naltrexone (LDN) and testosterone interaction covering pharmacokinetics, pharmacodynamic overlap, liver safety, hematocrit monitoring, and dose-adjustment guidance.
Can you take low-dose naltrexone (LDN) with trazodone? A physician-reviewed guide covering pharmacokinetic and pharmacodynamic interactions, sedation risk, monitoring protocols, and dose-adjustment strategies.
Can you take low-dose naltrexone (LDN) with warfarin? A clinician-reviewed guide covering CYP metabolism, INR monitoring, severity ratings, dose adjustments, and patient counseling.
A physician-reviewed guide to the low-dose naltrexone and zolpidem drug interaction, covering mechanism, severity, monitoring, dose adjustment, and patient counseling backed by primary literature.